원심 혈액 펌프 시장 : 기회, 성장 촉진요인, 산업 동향 분석 및 예측(2024-2032년)

The Global Centrifugal Blood Pumps Market was valued at approximately USD 95.1 million in 2023 and is projected to grow at 5.3% CAGR from 2024 to 2032. The rising prevalence of cardiovascular diseases (CVDs) significantly drives the market. Factors like an aging population, obesity, hypertension, and diabetes are increasing the incidence of heart failure and coronary artery disease. For instance, a 2023 study from the National Library of Medicine highlighted that about 6.7 million U.S. adults have heart failure (HF), a number projected to rise to 8.5 million by 2030. With a lifetime risk of 24%, it's estimated that one in four individuals will face heart failure at some point. Centrifugal blood pumps are pivotal in managing severe heart failure cases and intricate cardiac procedures, leading to improved patient outcomes and propelling market growth.

Technological advancements have played a crucial role in market expansion. Innovations like magnetic levitation technology, which minimizes mechanical wear and boosts pump reliability, have transformed the industry. Furthermore, the integration of advanced monitoring and control systems offers real-time insights into pump performance and patient conditions, enhancing safety and efficacy. These advancements not only elevate the performance and reliability of centrifugal blood pumps but also expand their application in both acute and chronic cardiovascular care, driving market growth.

The centrifugal blood pumps industry is classified based on product type, end-use, and region.

Divided into electrical and mechanical segments, the market forecasts the electrical segment to reach USD 113.8 million by 2032. Valued for their precision control and superior performance, electrical centrifugal blood pumps are becoming increasingly sought after in contemporary medical environments. These pumps, equipped with cutting-edge technology, allow real-time adjustments and heightened efficiency, especially during intricate surgical procedures or in critical care. Moreover, advancements in electronics and miniaturization are paving the way for more sophisticated and dependable electrical pumps, further boosting their market presence.

Segmented into short-term and long-term support applications, the long-term support segment leading with USD 37.1 million in 2023. This dominance stems from the rising demand for durable solutions to address chronic cardiovascular issues. The segment's strength is bolstered by the growing utilization of centrifugal pumps in advanced therapies like extracorporeal membrane oxygenation (ECMO) and ventricular assist devices (VADs). ECMO systems, vital for cardiac and respiratory support, necessitate long-term pump solutions for consistent operation. Likewise, VADs, aiding severe heart failure patients by enhancing blood pumping efficiency, greatly benefit from the durability and efficiency of centrifugal pumps designed for prolonged use.

The U.S. Centrifugal Blood Pumps Market is projected to hit USD 58.4 million by 2032. The rising prevalence of CVDs, including heart failure and coronary artery disease, is a primary driver. As these conditions become more common, the demand for advanced medical devices, particularly centrifugal blood pumps, surges, underscoring their importance in managing severe cardiac issues and supporting heart surgery patients.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing prevalence of cardiovascular diseases
    • 3.2.1.2 Technological advancements in centrifugal blood pumps
    • 3.2.1.3 Growing investment in cardiovascular research and development
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of devices
    • 3.2.2.2 Stringent regulatory scenario
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
  • 3.5.1 Core technologies
  • 3.5.2 Adjacent technologies
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTLE analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Electrical
• 5.3 Mechanical

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Short-term support
• 6.3 Long-term support

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Specialty clinics
• 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Abbott Laboratories
• 9.2 Braile Biomedica
• 9.3 Getinge AB
• 9.4 Hugo Sachs Elektronik
• 9.5 LivaNova PLC
• 9.6 Medtronic plc
• 9.7 Senko Medical Instrument Mfg. Co., Ltd.
• 9.8 Spectrum Medical
• 9.9 Terumo Corporation